Drug Trial Radar · NCT00054613
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
Last checked: Nov 20, 2026Latest source record: Aug 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Jun 2002
Primary completion
Not stated
Study completion Mar 2004
Sponsor
- Lead sponsor
- MallinckrodtIndustry
- Sponsor type
- Industry
- First posted
- Feb 6, 2003
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether extracorporeal photoimmune therapy with UVADEX (ECP) added to standard therapy is effective in the treatment of chronic graft-versus-host disease (GvHD).
Conditions
- Graft-versus-Host Disease
Interventions
MethoxsalenDrug
Extracorporeal PhotopheresisProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
31 sites in 12 countries. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences
Little Rock, Arkansas
University of Florida
Gainesville, Florida
Rush Presbyterian - St. Lukes Medical Center
Chicago, Illinois
University of Chicago
Chicago, Illinois
Tufts New England Medical Center
Boston, Massachusetts
Brigham and Womens
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Kansas City Cancer Center
Kansas City, Missouri
University of Nebraska
Omaha, Nebraska
Jewish Hospital
Cincinnati, Ohio
Fred Hutchinson Cancer Research Center
Seattle, Washington
Peter MacCallum
East Melbourne, Australia
Alfred Hospital
Melbourne, Australia
Royal Melbourne Hospital
Parkville, Australia
St. Vincent's Hospital
Darlinghurst, New South Wales, Australia
General Hospital of Vienna
Vienna, Austria
Hopital Edouard Herriot
Lyon, France
Hopital Pitie-Salpetriere
Paris, France
University of Dresden
Dresden, Germany
Universitatis Hautklinik
Essen, Germany
Universitatsklinikum Leipzig AOR
Leipzig, Germany
Ludwig-Maximilians-Universitaet Muenchen
München, Germany
Careggi Hospital
Florence, Italy
San Martino Hospital
Genova, Italy
Instituto Portugues de Oncologia de Francisco Gentil
Lisbon, Portugal
Klinika hematologie a transfuziologie FN
Bratislava, Slovakia
Hospital dela Santa Creu i Sant Pau. Universitat Autonoma de Barcelona
Barcelona, Spain
Kantonsspital Basel
Basel, Switzerland
Ankara University Medical School
Altındağ, Ankara, Turkey (Türkiye)
Glasgow Royal Infirmary
Glasgow, United Kingdom
Rotherham General Hospital
Rotherham, Yorkshire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.